Multimodal Imaging Market Size to Surpass USD 7.43 Billion by 2035 Driven by Technological Advancements and Rising Healthcare Demands

According to Precedence Research, the global multimodal imaging market size was valued at USD 4.52 billion in 2025 and is projected to surpass around USD 7.43 billion by 2035, growing at a compound annual growth rate (CAGR) of 5.10% from 2026 to 2035. This surge in growth is primarily fueled by rising healthcare demands, the adoption of hybrid imaging systems, and the shift towards non-invasive diagnostic techniques in hospitals, clinics, and research centers worldwide.

As the need for precise and non-invasive diagnostics increases, the adoption of multimodal imaging methods in hospitals, clinics, and research institutions becomes crucial for improving diagnostic accuracy and patient outcomes.

Where Data Meets Strategic Clarity 📥 View Sample Pages of the Complete Report 👉 https://www.precedenceresearch.com/sample/8150

Multimodal Imaging Market Growth Drivers

• Increasing prevalence of chronic diseases, such as cancer, neurological disorders, and heart diseases, is pushing the demand for advanced imaging techniques.

• Technological innovation, particularly the integration of artificial intelligence (AI) with imaging systems, is enhancing diagnostic precision and treatment planning.

• The need for non-invasive diagnostic methods that offer high spatial resolution and functional imaging is propelling market demand.

🔗 What's Fueling the Next Wave of Growth? 👉 https://www.precedenceresearch.com/multimodal-imaging-market

Emerging Opportunities in the Multimodal Imaging Market

• Emerging markets in Asia-Pacific are presenting immense growth opportunities, particularly due to rising healthcare investments and increasing access to advanced medical technologies.

• The growing emphasis on AI-driven personalized medicine is creating opportunities for new applications of multimodal imaging in targeted treatments

➡️ Become a valued research partner with us https://www.precedenceresearch.com/schedule-meeting

Multimodal Imaging Market Trends

• Technological Advancements: Ongoing developments in imaging technologies, such as the integration of AI, enhanced image resolution, and hybrid systems like PET/CT and PET/MRI, are reshaping diagnostic practices. New algorithms for improved image reconstruction and analysis are expected to revolutionize the way healthcare professionals interpret medical data.

• Personalized Medicine: With a focus on patient-specific care, multimodal imaging is driving the advancement of personalized treatment plans. The integration of molecular biology and radiogenomics is enabling targeted therapies that improve outcomes in oncology, neurology, and cardiology.

• Applications in Neuroscience: As neuroimaging becomes more critical in diagnosing and monitoring neuropsychiatric conditions, multimodal imaging is providing a clearer understanding of brain structure and function, aiding early detection and enhancing treatment strategies.

🔓 Instant Access. Zero Waiting. 📥 Buy the Premium Market Research Report Now 👉 https://www.precedenceresearch.com/checkout/8150

Regional Analysis

➤ Dominating Region

North America remains the largest market for multimodal imaging, accounting for approximately 40% of the global market share in 2025. Factors such as rising chronic disease rates, a large aging population, and robust healthcare investments continue to drive the market in the region.

The U.S. market was valued at USD 1.36 billion in 2025 and is projected to reach USD 2.27 billion by 2035 (CAGR 5.26%). Drivers include chronic disease prevalence, aging demographics, AI-driven hybrid systems, favorable reimbursement policies, and healthcare facility investments. Key players like Siemens Healthineers, GE Healthcare, and Philips lead innovation.

➤ Fastest-Growing Region

Asia-Pacific is poised to experience the fastest growth, with a projected CAGR of 5.5% from 2026 to 2035. Key factors contributing to this growth include rapid adoption of AI in healthcare, increasing government healthcare funding, and an expanding middle-class population with greater access to healthcare services.

India is rapidly advancing in multimodal imaging due to affordable local scanners, AI diagnostic tools, and government initiatives like 'Make in India' and Ayushman Bharat Health Infrastructure Mission. Growing chronic disease prevalence and improved healthcare access drive market expansion.

Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.

Try Before You Buy - Get the Sample Report@ https://www.precedenceresearch.com/sample/8150

Market Segmentation

🔸Modality Insights

The PET/CT segment dominated the multimodal imaging market in 2025, holding a 42% share. Its combination of functional and anatomical data enhances diagnostic accuracy, treatment planning, and patient care. PET/CT is widely used in oncology, neurology, cardiology, and infectious diseases, particularly for cancer staging and monitoring treatment responses.

PET/MRI is projected to grow fastest, with a CAGR of 4.3%. It aligns MRI's structural insights with PET's quantitative pathology, improving diagnostics in brain imaging, cardiology, and oncology. PET/MRI enhances precision medicine by enabling tailored treatment plans and a deeper understanding of biological and structural factors.

🔸Application Insights

Oncology accounted for the largest revenue share of 38% in 2025. Early detection, image-guided therapies, and sensitive screening programs reduce mortality and treatment side effects. Multimodal imaging is crucial for lesion detection, tumor staging, treatment response evaluation, and image-guided procedures.

Cardiology is expected to grow at a CAGR of 4.5%. Multimodal imaging is vital for early assessment, diagnosis, and management of cardiomyopathy. Combining echocardiography and cardiac MRI helps detect structural and functional abnormalities, supports risk stratification, and monitors treatment outcomes.

🔸End User Insights

Hospitals accounted for 55% of the market in 2025. High patient volumes, access to advanced equipment, and complex healthcare needs make hospitals the primary users of multimodal imaging. They benefit from skilled personnel, infrastructure, and resources for implementing sophisticated diagnostics.

Diagnostic imaging centers are expected to grow at a CAGR of 4.7%. They adopt PET-CT and PET-MRI technologies to manage high patient volumes, offer faster turnaround, and provide convenient locations. Outsourcing from hospitals to specialized centers also drives this growth.

✚ Explore More Market Intelligence from Precedence Research:

➡️ AI in Medical Imaging Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/ai-in-medical-imaging-market

➡️ Multiplex Biomarker Imaging Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/multiplex-biomarker-imaging-market

➡️ Diagnostic Imaging Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/diagnostic-imaging-market

➡️ Clinical Trial Imaging Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/clinical-trial-imaging-market

➡️ 3D Imaging Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/3d-imaging-market
➡️ Imaging Agents Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/imaging-agents-market

➡️ Magnetic Resonance Imaging Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/magnetic-resonance-imaging-market

➡️ Medical Imaging Workstations Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/medical-imaging-workstations-market

➡️ Thermal Imaging Market Size, Share and Trends 2026 to 2035 👉 https://www.precedenceresearch.com/thermal-imaging-market

Multimodal Imaging Market Companies and Their Offerings:

➤ Siemens Healthineers offers Nexaris Therapy Suites that integrate multimodal imaging like CT, angiography, and MR for surgery and interventional radiology, enabling seamless image fusion and efficient workflows.

➤GE Healthcare develops multimodal AI foundation models for X-ray and 3D MRI, supporting tasks like segmentation, classification, and full-body imaging analysis.

➤Canon Medical Systems provides a range of multimodal solutions, including CT, MRI, ultrasound, X-ray, and mobile hybrid systems like CT Hybrid Elite for versatile diagnostic and interventional use.

➤Philips Healthcare features 3T MRI systems with MultiTransmit RF technology and SmartSpeed AI for advanced neuro, MSK, body, and molecular imaging with improved uniformity and speed.

➤Bruker Corporation specializes in preclinical multimodality systems combining BioSpec MRI (up to high fields), PET, SPECT, and microCT like Albira Si for simultaneous functional and anatomical imaging.

➤Shimadzu Corporation delivers the Multimodal Imaging System integrating LA-ICP-MS for elemental distribution and MALDI-MS microscopy (iMScope QT) for molecular imaging analysis.

➤Mediso Medical Imaging offers AnyScan platforms with SPECT/CT, PET/CT, and theranostic systems using advanced detectors for high-performance nuclear medicine imaging.

➤Carestream Health supports multimodality mammography workstations for reviewing FFDM, ultrasound, MR, and CR, enhancing diagnostic workflows with CAD integration.

➤PerkinElmer (Revvity) provides preclinical IVIS systems for optical, bioluminescence, fluorescence tomography, and microCT (Quantum GX2), enabling multimodal in vivo studies in oncology and more.

➤FUJIFILM Holdings Corporation launches Vevo F2, a multimodal preclinical ultrasound platform for high-resolution imaging.

➤Spectrum Dynamics Medical features CZT-based digital SPECT/CT systems like VERITON-CT for total-body and cardiology imaging with fast scans and attenuation correction.

➤NeuroLogica Corporation (Samsung) offers OmniTom Elite mobile CT with photon-counting detectors for point-of-care stroke and trauma imaging, supporting multi-energy data acquisition.

➤MR Solutions develops cryogen-free preclinical multimodality systems (PET/MR/CT/SPECT) with clip-on SPECT and integrated PET for molecular imaging up to 9.4T MRI.

➤Life Molecular Imaging focuses on PET radiotracers for neurology (e.g., amyloid imaging) and cardiology, supporting molecular diagnostics in Alzheimer's and cardiovascular applications.

➤MOBILAB Imaging provides portable diagnostic devices (Uni-D, Duo-D) for rapid point-of-care tests, though primarily non-imaging; limited multimodal radiology offerings found.

Latest Industry Developments

🔹In February 2026, Merck and the Mayo Clinic formed a strategic partnership to leverage multimodal clinical data and AI in faster drug discovery and target identification, focusing on autoimmune and neurological diseases.

🔹In May 2025, Google launched MedGemma, a platform designed to assist developers in creating AI-powered healthcare applications. The platform's multimodal version will enhance medical imaging in fields such as radiology, digital pathology, and dermatology.

Segments Covered in the Report

🔹By Modality

PET/CT
SPECT/CT
PET/MRI
Optical/CT
Others

🔹By Application

Oncology
Neurology
Cardiology
Orthopedics
Others

🔹By End User

Hospitals
Diagnostic Imaging Centers
Research Institutes
Others

🔹By Region

North America
Latin America
Europe
Asia-pacific
Middle and East Africa

Connect With Us

📞 USA: +1 804 441 9344
📞 APAC: +61 485 981 310 or +91 87933 22019 | +6531051271
📞 Europe: +44 7383 092 044
📩 Email: sales@precedenceresearch.com

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

🌐 Web: https://www.precedenceresearch.com

Our Trusted Data Partners:
🔹https://www.towardshealthcare.com
🔹https://www.towardspackaging.com
🔹https://www.towardschemandmaterials.com
🔹https://www.towardsfnb.com
🔹https://www.marketstatsinsight.com

Get Recent News:
https://www.precedenceresearch.com/news

For the Latest Update, Follow Us:
🔹https://www.linkedin.com/company/precedence-research
🔹https://x.com/Precedence_R
🔹https://www.facebook.com/precedenceresearch
🔹https://precedence-research.medium.com/

This release was published on openPR.